The impact of oral contraception on vulvovaginal candidiasis
Reference (13)
Pathophysiology of vulvovaginal candidiasis
J Reprod Med
(1989)- et al.
Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis
Obstet Gynecol
(1993) Candidosis of the genitalia
Modern epidemiology
(1986)Simple estimation of population attributable risk from case-control studies
Am J Epidemiol
(1977)The epidemiology of vulvovaginal candidiasis: Risk factors
Am J Public Health
(1990)
There are more references available in the full text version of this article.
Cited by (80)
3D printing fabrication of Ethylene-Vinyl Acetate (EVA) based intravaginal rings for antifungal therapy
2023, Journal of Drug Delivery Science and TechnologyThe occurrence of vulvovaginal Candida species and their antifungal susceptibility pattern in HIV seropositive women in Ahvaz, Southwest Iran
2020, Clinical Epidemiology and Global HealthCitation Excerpt :A high rate of VVC was reported in women in the age range of the 20–29 years in many studies,17,28 which was consistent with our findings (24.68 ± 8.99 years), probably due to drug usage and or contraceptives. Spinillo et al. reported a high rate of Candidiasis among married women between 30 and 45 years with frequent sexual activity, reproductive history, and taking contraceptives.29 Our findings showed that the rate of pregnancy is significantly more frequent among women with VVC.
Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d'Ivoire): Aetiology and associated factors
2019, Journal de Mycologie MedicaleVulvovaginitis and Cervicitis
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious DiseasesFSRH Guideline (March 2023) Intrauterine contraception
2023, BMJ Sexual and Reproductive Health
Copyright © 1995 Published by Elsevier Inc.